StockData
Innate Pharma SA logo

Innate Pharma SA (IPHA) income statement

IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 0/30
$1.03−0.30 (-22.56%)

Close on Nov 18, 2026Market cap $96.53MP/E –Yield –

See a number that looks wrong?